American Society of Hirudotherapy

Broad geographic sampling and DNA barcoding do not support the presence of Helobdella stagnalis in North America

Taxonomy study published in Zootaxa (2019)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomics & ProteomicsIwama RE et al. · Zootaxa, 2019

Abstract

The description of Helobdella stagnalis (Linnaeus, 1758) has emphasized the presence of a nuchal, chitinous scute located on the dorsal surface in the first third of the body as the diagnostic character for the species. Historically, identifications of species of Helobdella have relied heavily on this character and, as a result, Helobdella stagnalis has been reported from an inordinately broad geographic range, including Europe, Asia, Africa, North America, and South America. In addition to a few earlier investigations, a recent analysis showed that great genetic distances (orders of magnitude greater than previous estimations of intraspecific divergence in leeches) are present between scute-bearing specimens identified as H. stagnalis from Europe and North America, implying that H. stagnalis does not occur in North America. The present study expands the geographic boundaries of taxon sampling for both European and North American taxa, and re-examines the phylogenetic relationships and cytochrome c oxidase subunit I (COI) variation within scute-bearing species of the genus Helobdella. Our analyses include specimens putatively identified as "Helobdella stagnalis" from Sweden, Norway, Iceland, England, France, Italy, Slovenia, Turkey, Russia, and Iran, as well as numerous localities covering Canada and the USA. Our results corroborate previous studies in that European and west Asian specimens form a clade, including the neotype, which is separate from North American taxa. To alleviate future taxonomic confusion, we redescribe H. stagnalis and designate a neotype from the inferred type locality. The designation of a neotype stabilizes the taxonomy of scute-bearing leeches of the genus Helobdella and enables us to definitively correct erroneous identifications reported in previous studies. We also note that at least four lineages of scute-bearing, North American species of Helobdella lack formal descriptions.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsDNA Barcoding, TaxonomicLeechesNorth AmericaPhylogeny

Summary

Demonstrates via geographic sampling and DNA barcoding that 'Helobdella stagnalis' records from North America are misidentifications — important taxonomic correction.

Why This Matters for Hirudotherapy

This study used broad geographic sampling and COI DNA barcoding to re-examine the phylogenetic relationships and species boundaries within scute-bearing leeches of the genus Helobdella, testing whether H. stagnalis truly occurs in North America. Analyzing specimens from Europe, western Asia, Canada, and the USA, the authors corroborated that European and west Asian scute-bearing leeches form a clade separate from North American taxa, redescribed H. stagnalis, and designated a neotype from the inferred type locality to stabilize taxonomy. The study has no direct relevance to medicinal leech applications, the leech secretome, or therapeutic practice, though it contributes to leech systematics and underscores how morphological characters alone can mislead leech species identification. No connection to hirudotherapy is evident from the abstract.

Citation

Broad geographic sampling and DNA barcoding do not support the presence of Helobdella stagnalis in North America.

Iwama RE et al. · Zootaxa, 2019

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.